Abstract
Flecainide is an antiarrhythmic agent indicated for patients with supraventricular arrhythmias without ischemic or structural heart disease. Flecainide toxicity is a rare condition in which patients may present with bradycardia, widening of QRS, PR prolongation, ventricular tachycardia, syncope, malaise, dizziness, visual disturbance, nausea, vomiting, and/or lethargy. It carries an associated mortality rate of approximately 10%. Herein, we describe the course of a patient who experienced flecainide toxicity in the setting of renal and liver failure.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 378-379 |
| Number of pages | 2 |
| Journal | Baylor University Medical Center Proceedings |
| Volume | 34 |
| Issue number | 3 |
| DOIs | |
| State | Published - 2021 |
| Externally published | Yes |
Keywords
- Antiarrhythmic
- flecainide
- supraventricular tachycardia
ASJC Scopus subject areas
- General Medicine
Fingerprint
Dive into the research topics of 'Flecainide toxicity late after liver transplantation'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS